aminolevulinic acid has been researched along with Atherogenesis in 4 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We and other groups have demonstrated that 5-aminolevulinic acid (ALA)-mediated sonodynamic therapy (ALA-SDT) induces macrophage and foam cell apoptosis and stabilizes atherosclerosis (AS) plaques in animal models." | 7.88 | 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization. ( Chen, X; Gong, J; Huang, Z; Jin, H; Liu, Y; Shen, Z; Shi, Y; Tian, Y; Tian, Z; Wang, W; Wang, Y; Yang, Y; Yao, J, 2018) |
| "In this study, 5-aminolevulinic acid (ALA) gold nanoparticles (ALA:AuNPs) functionalized with polyethylene glycol (PEG) were synthesized and administered to rabbits to evaluate their use in clinical practice as theranostic agents for atherosclerosis." | 7.81 | Aminolevulinic acid with gold nanoparticles: a novel theranostic agent for atherosclerosis. ( Courrol, LC; da Silva, MN; de Matos, RA; de Oliveira Gonçalves, K; de Oliveira Silva, FR; Sicchieri, LB, 2015) |
| "We and other groups have demonstrated that 5-aminolevulinic acid (ALA)-mediated sonodynamic therapy (ALA-SDT) induces macrophage and foam cell apoptosis and stabilizes atherosclerosis (AS) plaques in animal models." | 3.88 | 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization. ( Chen, X; Gong, J; Huang, Z; Jin, H; Liu, Y; Shen, Z; Shi, Y; Tian, Y; Tian, Z; Wang, W; Wang, Y; Yang, Y; Yao, J, 2018) |
| "In this study, 5-aminolevulinic acid (ALA) gold nanoparticles (ALA:AuNPs) functionalized with polyethylene glycol (PEG) were synthesized and administered to rabbits to evaluate their use in clinical practice as theranostic agents for atherosclerosis." | 3.81 | Aminolevulinic acid with gold nanoparticles: a novel theranostic agent for atherosclerosis. ( Courrol, LC; da Silva, MN; de Matos, RA; de Oliveira Gonçalves, K; de Oliveira Silva, FR; Sicchieri, LB, 2015) |
| "Sixty rabbits were induced atherosclerotic plaques in the femoral artery with a combination of silastic tube placement with atherogenic diet, and randomly assigned into control (n = 12) and SDT (n = 48) groups." | 1.42 | Rapid stabilisation of atherosclerotic plaque with 5-aminolevulinic acid-mediated sonodynamic therapy. ( Cao, W; Guo, S; Li, Z; Peng, C; Sun, X; Tian, Y; Tian, Z; Wang, L; Wang, T; Wang, W; Zhao, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 1 |
| Liu, Y | 1 |
| Chen, X | 1 |
| Gong, J | 1 |
| Huang, Z | 1 |
| Wang, W | 3 |
| Shi, Y | 1 |
| Wang, Y | 1 |
| Yao, J | 2 |
| Shen, Z | 1 |
| Tian, Z | 3 |
| Jin, H | 1 |
| Tian, Y | 3 |
| de Oliveira Gonçalves, K | 1 |
| da Silva, MN | 1 |
| Sicchieri, LB | 1 |
| de Oliveira Silva, FR | 1 |
| de Matos, RA | 1 |
| Courrol, LC | 1 |
| Li, Z | 1 |
| Sun, X | 2 |
| Guo, S | 2 |
| Wang, L | 1 |
| Wang, T | 1 |
| Peng, C | 1 |
| Zhao, R | 1 |
| Cao, W | 2 |
| Tian, F | 1 |
| Yan, M | 1 |
| Gao, W | 1 |
| Dong, Z | 1 |
| Li, B | 1 |
| Gao, T | 1 |
| Shan, P | 1 |
| Liu, B | 1 |
| Wang, H | 1 |
| Cheng, J | 1 |
| Gao, Q | 1 |
| Zhang, Z | 1 |
4 other studies available for aminolevulinic acid and Atherogenesis
| Article | Year |
|---|---|
5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Atherosclerosis; Humans; Jurkat Cells; Male; Membrane Poten | 2018 |
Aminolevulinic acid with gold nanoparticles: a novel theranostic agent for atherosclerosis.
Topics: Aminolevulinic Acid; Animals; Aorta; Atherosclerosis; Fluorescence; Gold; Male; Nanoparticles; Photo | 2015 |
Rapid stabilisation of atherosclerotic plaque with 5-aminolevulinic acid-mediated sonodynamic therapy.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Atherosclerosis; Cholesterol; Collagen; Disease Models, Ani | 2015 |
5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells.
Topics: Aminolevulinic Acid; Apoptosis; Atherosclerosis; Caspase 3; Caspase 8; Cell Line, Tumor; Foam Cells; | 2016 |